Meet with us at BIO International! June 16-19 in Boston   Schedule a meeting!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

cell therapy services from AGC Biologics will support Quell Therapies

2 min read

AGC Biologics Partners with Quell Therapeutics to Advance T-Regulatory Cell Therapies for Immune Disorders

May 15, 2025 at 3:45 AM
Press Release
Read press release
AGC Biologics to support Novelty Nobility for antibody drug candidate

2 min read

AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate

May 5, 2025 at 4:00 PM
Press Release
Read press release
AGC Biologics Yokohama Facility begins GMP production in 2027

2 min read

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

April 7, 2025 at 3:51 PM
Press Release
Read press release
AGC Biologics announces new cell and gene business division

3 min read

AGC Biologics Launches New Dedicated Cell and Gene Business Division

April 2, 2025 at 12:25 PM
Press Release
Read press release

1 min read

AGC Biologics Honored at CDMO Leadership Awards for Excellence in Quality, Biologics and Cell and Gene Therapies

March 10, 2025 at 2:41 PM
Press Release
Read press release
Adaptimmune and AGC Biologics Partnership

2 min read

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

January 16, 2025 at 5:30 AM
Press Release
Read press release
AGC Biologics’ Cell and Gene Center of Excellence expands exosome work with new project.

2 min read

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

January 9, 2025 at 9:09 AM
Press Release
Read press release
New leadership roles to drive operational readiness and regional growth for the company in Japan

1 min read

AGC Biologics Announces Leadership Updates Amid Groundbreaking of New Yokohama Site

December 22, 2024 at 6:00 PM
Press Release
Read press release
AGC Biologics CMC Jumpstart™ Program Offers Platform Assessments

2 min read

New AGC Biologics CMC Jumpstart™ Program Offers CGT Developers Viral Vector Platform Assessments that Control Costs and Analyze Feasibility

December 18, 2024 at 9:15 AM
Press Release
Read press release
Autolus and AGC Biologics

2 min read

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

December 11, 2024 at 9:00 AM
Press Release
Read press release
1 2 3 4 5 Next